Quantitative evaluation of data is the foundation of scientific research. The Biostatistics Core provides resources to assist in the planning, conduct and analysis of the proposed research in such a way that quantitative analyses are appropriate and illuminating. The Core also assists in the dissemination of appropriate information both within and external to the SPORE and the Siteman Cancer Center (SCC). This core represents an extension of the strong Biostatistics Core within the Siteman Cancer Center, and funding is only requested for the SPORE-specific support required. This efficient model takes advantage of the core infrastructure in place. The Core is staffed by a dedicated biostatistician for each of the 4 projects. In addition a designated faculty member is devoted to collaborations concerning specialized bioinformatics issues. The Core staff are collaborators with the Project Co-leaders. The staff of the Core will meet weekly among themselves and regulariy with Project leaders to review the progress in each Project and the SPORE overall and to discuss methodological issues. The Biostatistics Core will serve as a resource and collaborator for the four main projects proposed in this application. Career Development Program and Developmental Research Program projects and the SPORE Cores. Specifically the Biostatistics Core will: 1. Continue to participate in the design of all projects (including developmental and career development) and will advocate for the application of appropriate statistical and methodological techniques. 2. Continue to merge information from the SPORE research with information about samples that have been entered into caTISSUE which is supported by the SPORE Tissue and Pathology Core to produce analytic datasets which are deidentified and easily distributed to investigators. 3. Collaborate in data analysis and report preparation for all Cores and Projects. 4. Collaborate in the design of all forms to be used. 5. Support data entry and data management procedures to achieve cost-effective data acquisition. 6. Facilitate access to data collected by the projects and cores.
This shared resource will acquire and store tissue samples (blood and bone marrow) from patients with leukemia. These samples will be invaluable to investigators as they test new hypotheses and therapies.
|Ghobadi, Armin; Choi, Jaebok; Fiala, Mark A et al. (2016) Phase I study of azacitidine following donor lymphocyte infusion for relapsed acute myeloid leukemia post allogeneic stem cell transplantation. Leuk Res 49:1-6|
|Al-Hussaini, Muneera; Rettig, Michael P; Ritchey, Julie K et al. (2016) Targeting CD123 in acute myeloid leukemia using a T-cell-directed dual-affinity retargeting platform. Blood 127:122-31|
|Welch, John S; Petti, Allegra A; Miller, Christopher A et al. (2016) TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes. N Engl J Med 375:2023-2036|
|Rashidi, Armin; Ebadi, Maryam; Colditz, Graham A et al. (2016) Outcomes of Allogeneic Stem Cell Transplantation in Elderly Patients with Acute Myeloid Leukemia: A Systematic Review and Meta-analysis. Biol Blood Marrow Transplant 22:651-7|
|Fehniger, Todd A; Cooper, Megan A (2016) Harnessing NK Cell Memory for Cancer Immunotherapy. Trends Immunol 37:877-888|
|Wong, Terrence N; Miller, Christopher A; Klco, Jeffery M et al. (2016) Rapid expansion of preexisting nonleukemic hematopoietic clones frequently follows induction therapy for de novo AML. Blood 127:893-7|
|Rashidi, Armin; Walter, Roland B; Tallman, Martin S et al. (2016) Maintenance therapy in acute myeloid leukemia: an evidence-based review of randomized trials. Blood 128:763-73|
|Shirai, Cara Lunn; Ley, James N; White, Brian S et al. (2015) Mutant U2AF1 Expression Alters Hematopoiesis and Pre-mRNA Splicing In Vivo. Cancer Cell 27:631-43|
|Wong, Terrence N; Ramsingh, Giridharan; Young, Andrew L et al. (2015) Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemia. Nature 518:552-5|
|Uy, Geoffrey L; Hsu, Yen-Michael S; Schmidt, Amy P et al. (2015) Targeting bone marrow lymphoid niches in acute lymphoblastic leukemia. Leuk Res 39:1437-42|
Showing the most recent 10 out of 32 publications